ABSTRACT
INTRODUCTION
Kidney is a vital organ of human body and its structure is bean shaped made up of two lobes. [1] Kidneys perform a large number of important functions such as controlling body fluids volume and composition, as well as removal of metabolic wastes from body. [2, 3] Renal cell carcinoma also called renal adenocarcinoma or kidney cancer, it is a disease in which malignant cells are found in the lining of tubules in the kidney. It is the eighth most common malignancy which affect adults, and accounts for 3% to 4% of new cancer cases arising in U.S and is the 7 th most common cancer in men and 9 th most common cancer in women. Renal cell carcinoma (RCC) accounts for over 80% of the kidney cancers. [4] [5] [6] [7] For treating the renal cell carcinoma patient immunotherapy is considered as the core therapeutic option. High dose produce 15-18% response, also 6-7% remission along with 4-5% of cure rate. Bevacizumab and interferon-α as a combined dose and Immunotherapy with heavy-dose of interleukin 2 [IL-2] are approved to be effective treatments. [8, 9] Vascular endothelial growth factor (VEGF) is a principal controller of vascular development and lymphatic vessel function during health and disease in the adult. The growth of new vessel formation is known as angiogenesis. VEGF is the key player in tumor angiogenesis. [10] Inhibition of VEGF stimulates angiogenesis that may give rise to tumor growth and metastatic potential in RCC. [11, 12] For the treatment of RCC VEGF inhibitors have been established. [10, 13] Oxidative stress initiates the instruction of DNA damage and insert its effects on intracellular signal transduction pathways because it plays a significant part in carcinogenesis. [14] There is an increase in Oxidative stress in renal cell carcinoma. Based upon these facts, this study was design to evaluate the potential of RCC patient derived serum for tumor angiogenesis via measuring its vascular endothelial growth factor (VEGF) levels and anti-oxidative enzyme levels in an attempt to understand the metastasis of RCC in Pakistani Population. 
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Sample Collection
Serum samples from the patients diagnosed with RCC were randomly collected from Agha Khan Laboratory, Lahore, Pakistan. A total of 100 normal subject and 100 RCC patients' serum and biopsies of 50 patients were included in the study who belong to province Punjab.
Assessment of Angiogenesis
Levels of VEGF (an angiogenesis marker) were evaluated via solid phase sandwich enzymelinked immunosorbent assay (ELISA) and immune-histochemical analysis.
ELISA
ELISA was done as reported previously [15, 16] . Solid phase sandwich ELISA was done for Using a micro-titer plate reader, absorbance was taken at a wavelength of 450 nm along with 650 nm as a reference value.
Immunohistochemical Analysis
Tissues slides were taken from paraffin embedded biopsy samples. Immunohistochemical staining protocol was followed as reported. [17, 18] Briefly, three sections per biopsy were deparafinized and fixed in 4% paraformaldehyde (PFA). To block nonspecific binding, tissue sections were treated with 5% BSA and cells were stained with primary rabbit polyclonal VEGF antibody (Santa Cruz biotechnology, USA). After incubation, cells were washed and incubated with fluorescein isothiocyanate (FITC) conjugated goat anti rabbit secondary antibody (Santa Cruz biotechnology, USA). Fluorescent images were taken by microscope with DP-70 camera (Meiji, Japan). Lactate dehydrogenase (LDH) activity was calculated in the serum of both groups. The assessment of LDH release was done according to the manufacturer's instructions (AMP Diagnostics, GmbH). The assay was performed by incubating the mixing 5ul serum from each group and 95ul of working reagent for 5 min. The absorbance was taken at 340 nm.
Lactate dehydrogenase (LDH) assay
Assessment of Anti-Oxidative enzymes
Evaluation of anti-oxidative enzymes in both groups was done via measuring the levels Superoxide dismutase (SOD), Ascorbate peroxidase (APOX), Glutathione peroxidase (GSH)
and Catalase (CAT) in serum.
Superoxide dismutase (SOD) Assay
SOD assay was performed with slight modifications in the reported protocol. [19] For preparation of reaction, the following components were added, 0.1 mM EDTA, 100 mM KH2PO4 buffer (pH 7.8), 60 mM riboflavin, 13 mM methionine, 2.25 mM NBT (Nitro blue tetrazolium) and remaining was serum. After mixing all the components, the reaction plate was exposed to light for 10 minutes. Optical density was taken at 560nm.
Ascorbate peroxidase (APOX) Assay
Apox assay was performed with slight modifications in the reported protocol. [19] For preparation of reaction the added components are, 0.5 mM ascorbate, 0.3 mM H 2 O 2 , 100 mM KH 2 PO 4 buffer (pH 7.0) and remaining was serum. Optical density at 290 nm was taken after 3 minutes.
Glutathione (GSH) Assay
GSH assay was performed as reported previously [19] with slight modifications. Reaction was prepared by adding 1 mM EDTA, 0.5 mM oxidized glutathione, 100 mM KH 2 PO 4 buffer (pH 7.5) and remaining serum were added. For starting the reaction 0.2 mM NADPH was added in the end. The reaction was permitted to proceed for 3 min. Absorbance of reaction was taken at 340 nm.
Catalase (CAT) Assay
CAT assay was performed with slight modifications in the reported protocol. [19] Buffer used for reaction contain 12.5 mM H 2 O 2 in 50 mM KH 2 PO 4 (pH 7.0). 100ul serum was added in it.
In this assay plates were placed in dark and absorbance was taken at 240nm after 45 and 60seconds. CAT activity was estimated by using the difference between 45 and 60seconds. 
RESULTS
Assessment of Angiogenic Potential
The potential of angiogenesis in RCC was determined by measuring the VEGF levels in the serum obtained from diseased (RCC) and normal groups. Immunostaining of RCC section was done via VEGF antibody in order to determine cellular levels of angiogenesis while ELISA methods was used to investigate the levels of VEGF in serum of RCC patients as well as normal subjects. Staining of tissue section of RCC revealed high level of angiogenesis which is a prerequisite for tumor progression and growth (Fig 1) . Moreover, VEGF levels were increased significantly in diseased group (0.735±0.023) as compared to normal group (0.387±0.015) as evidenced from the graph (Fig 1B) . 
LDH Release Assay
Lactate dehydrogenase (LDH) is common injury marker and disease, it is released as a response to tissue damage. The levels of LDH were measured in the serum obtained from normal and diseased groups. It is evidenced form the graph that levels of LDH were significantly higher in diseased group (12.9±0.3) as compared to normal group (8.25±0.1) (Fig 2) . Values were expressed as mean ± SEM (normal vs. diseased * p< 0.05).
Assessment of anti-oxidative enzymes Super Oxide Dismutase (SOD)
Percentage of Super Oxide Dismutase (SOD) was measured in blood serums that were obtained from the normal and disease groups. SOD percentage was compared in both groups.
SOD percentage was lower in disease group (57.4±1.07) and higher in normal group (91.0±0.41) shown in (Fig 3A) .
Glutathione (GSH)
Percentages of Glutathione were estimated in blood serums that were obtained from the normal and disease groups. Percentages of GSH were compared in both groups. GSH percentage was lower in disease group (7.53±0.25) and higher in normal group (28.5±1.07) ( Figure 3B ).
Catalase (CAT)
For the estimation of percentages of Catalase obtained from the blood serums of normal and RCC subjects. Catalase percentage was lower in disease group (5.89±0.49) and higher in normal group (18.0±0.07) ( Figure 3C ).
Ascorbate peroxidase (APOX)
APOX assay was done by measuring the levels of APOX from the blood serums of diseased group and normal one. APOX percentage was decreased in disease group (11.4±0.4) and increased in normal group (17.8±0.9) (Fig 3D) . 
DISCUSSION
Renal cell carcinoma (RCC or hypernephroma) is one of the most common type of kidney cancer that initiates in the parenchyma of very small tubules in the kidney and accounts for most of the renal malignancies. [11, [20] [21] [22] Angiogenesis and oxidative stress play an significant role in the pathogenesis of RCC, therefore, this study investigates the anti-oxidative status and angiogenic potential of the RCC patients derived serum was determined via determining their vascular endothelial growth factor and anti-oxidative enzyme levels. Blood samples were collected from 100 renal cell carcinoma (RCC) patients and 100 normal subjects and serum was isolated for anti-oxidative enzyme assays and ELISA. The process of new blood vessel formation is called angiogenesis which is necessary for embryologic development, tissue repair and normal growth. [23] Moreover, it is a prerequisite for tumor growth, progression, invasion, metastasis and prognosis. [24] [25] [26] Therefore, targeting the angiogenesis of a tumor may result in inhibition of tumor growth and progression. [25, 27] In this study increased angiogenesis has accounted as a marker for tumor progression, therefore, RCC patients have more levels of VEGF in their serum compared to normal ones (Fig: 1) .
Anti-angiogenesis is one of the most popular clinical interventions for cancer chemotherapy. [23] [24] [25] [26] The key factor for angiogenesis is vascular endothelial growth factor (VEGF), therefore VEGF has been believed to be a central target for anti-angiogenic therapies. [28] [29] [30] Most cancer cells including RCC use aerobic glycolysis to fuel their growth and targeting LDH is promising for tumor inhibition. [31] Increased LDH is an undesirable risk factor for survival of renal cell carcinoma. [32, 33] Therefore, serum sample taken from RCC patients show elevated serum level of LDH ( Figure: 2).
Oxidative stress-mediated DNA damage has been reported to inhibit RCC and play a pivotal role in RCC pathogenesis. [33] [34] [35] It has been reported that oxidative stress play a significant positive effects on the growth and progression of RCC. [36] [37] [38] [39] Strong anti-oxidants are reported to have strong anticancer abilities. [40] Moreover, agents that causes reduction in anti-oxidative enzymes are reported to have significant effects on tumor progression markers. [41] Previously reported data suggest a significant decrease in the levels of anti-oxidative enzymes in serum of RCC patient. [36, 42] Decreased levels of anti-oxidative enzymes (SOD, CAT, GSH and APOX) in the present finding can be a cause of progression of RCC in patients ( Figure 3 ).
Thus, this study will helps in understanding the angiogenesis and anti-oxidative status of RCC patients as evidenced from their VEGF and anti-oxidative enzyme level profiling.
Further, this information will aid in investigating the mechanism of progression of RCC. Our results show that the enhanced angiogenic property of serum and a downfall in anti-oxidative enzymes status could play a crucial role in renal cell carcinoma progression and metastasis in Punjabi population.
